Companies Dominating the Dry Eye Syndrome Landscape
- Lumenis Be Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson Services Inc.
- Alcon Vision LLC
- Allergan (AbbVie)
- Novartis AG
- Allostera Pharma Inc.
- I-Med Pharma Inc.
- Acadia Pharmaceutical Inc.
- Otsuka Pharmaceutical Co. Ltd.
- Sun Pharmaceutical Industries Ltd.
Browse Key Market Insights with Data Illustration:
In the News
-
Alcon launched its latest innovation, Systane iLux2 MGD Thermal Pulsation system, it enhances the dry eye care. This new imaging technology capture HD videos and infrared photos and enables patients to have better understanding about their problem.
-
Novartis AG announced the acquisition of Xiidra, the first ever prescription approved to treat the early signs and symptoms of dry eye problems by preventing inflammation caused by the disease.
